Good Samaritan Society - Maplewood: Insulin Cross-Contamination - MN
Federal inspectors found the dangerous practice across all three medication carts on the facility's transitional care unit during a complaint investigation in late August. The deficient storage method affected every resident requiring insulin administration via pen devices.
At 10:38 a.m. on August 27, registered nurse RN-E pulled an insulin pen from a plastic cup inside a red tote at the bottom of a medication drawer. The cup contained insulin pens prescribed for multiple residents, with no barrier separating the devices.
"This was the way the insulin pens had always been stored after opening," RN-E told inspectors. The nurse explained all the pens were kept together "touching each other without a barrier between."
Two hours later, RN-F opened the remaining medication carts on the unit. She confirmed that several different residents' insulin pens were stored together without barriers separating them.
"Not being aware the insulin pens should not be stored together and touching other resident's pens," RN-F said this was standard practice since she began working at the facility.
The contamination risk stems from external contact with the devices, even without visible blood. The facility's own policy on insulin administration, dated September 5, 2024, explicitly warned that "contamination of these devices [insulin pens] can occur externally [even in the absence of visible blood] resulting in the potential for transmission of blood borne pathogens when used for multiple people."
Despite having written policies addressing the issue, nursing staff remained unaware of proper storage requirements. RN-A, interviewed the same day, said she "was not aware of an issue with insulin pens being stored together." She thought insulin pens should only be stored separately from other types of medication, not from other residents' insulin devices.
The facility's director of nursing expressed similar ignorance about basic infection control requirements. During her interview at 1:36 p.m., the DON admitted she "was not aware insulin pens needed to be stored separated by resident or with a barrier between each resident's pen, but thought it was a good idea."
Only the facility's infection preventionist understood the safety protocols. During her interview at 1:31 p.m., she correctly explained that each resident's insulin pens should be separated from other residents' devices. She noted that separating the pens with barriers "would prevent possible cross contamination."
The facility maintained a second relevant policy on medication storage dated March 4, 2025, requiring that "all medication will be stored in accordance with manufacturers' recommendations" and directing staff to refer to the insulin administration policy for specific guidance.
The widespread nature of the violation suggested systemic failures in staff training and policy implementation. All three medication carts on the transitional care unit demonstrated the same dangerous storage practices, indicating the problem extended beyond individual nurse error to institutional negligence.
Insulin pens are designed as single-patient devices specifically to prevent cross-contamination. When multiple residents' pens touch each other during storage, any external contamination on one device can transfer to others, potentially exposing vulnerable diabetic patients to infectious diseases.
The inspection occurred following a complaint, suggesting someone inside or outside the facility recognized the dangerous practices and reported them to state health officials. The minimal harm classification indicated inspectors found no evidence that residents had actually contracted infections, but the potential for serious harm remained significant.
The facility's own policies contained the knowledge necessary to prevent the violations, yet multiple levels of nursing staff remained uninformed about basic infection control requirements for insulin devices. The gap between written policy and actual practice highlighted broader concerns about staff education and oversight at the
Good Samaritan Society facility.
The contamination risk affected every resident requiring insulin administration, a particularly vulnerable population given their diabetes diagnosis and potential for compromised immune systems. The storage violations created unnecessary exposure to bloodborne pathogens for patients who trusted the facility to maintain basic safety standards during their medical care.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Good Samaritan Society - Maplewood from 2025-08-28 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: Official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).
Editorial process: AI-synthesized regulatory data, reviewed for accuracy by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: June 20, 2026 · Our methodology
GOOD SAMARITAN SOCIETY - MAPLEWOOD in SAINT PAUL, MN was cited for violations during a health inspection on August 28, 2025.
The deficient storage method affected every resident requiring insulin administration via pen devices.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.